MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1420-9071
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease ; volume:73 ; number:1 ; day:23 ; month:7 ; year:2015 ; pages:217-236 ; date:1.2016
Cellular and molecular life sciences ; 73, Heft 1 (23.7.2015), 217-236, 1.2016

Creator
Baranger, Kevin
Contributor
Marchalant, Yannick
Bonnet, Amandine E.
Crouzin, Nadine
Carrete, Alex
Paumier, Jean-Michel
Py, Nathalie A.
Bernard, Anne
Bauer, Charlotte
Charrat, Eliane
Moschke, Katrin
Seiki, Mothoharu
Vignes, Michel
Lichtenthaler, Stefan F.
Checler, Frédéric
Khrestchatisky, Michel
Rivera, Santiago
SpringerLink (Online service)

DOI
10.1007/s00018-015-1992-1
URN
urn:nbn:de:1111-2016090410575
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Baranger, Kevin
  • Marchalant, Yannick
  • Bonnet, Amandine E.
  • Crouzin, Nadine
  • Carrete, Alex
  • Paumier, Jean-Michel
  • Py, Nathalie A.
  • Bernard, Anne
  • Bauer, Charlotte
  • Charrat, Eliane
  • Moschke, Katrin
  • Seiki, Mothoharu
  • Vignes, Michel
  • Lichtenthaler, Stefan F.
  • Checler, Frédéric
  • Khrestchatisky, Michel
  • Rivera, Santiago
  • SpringerLink (Online service)

Other Objects (12)

MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?

MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?

Modeling Alzheimer’s disease in transgenic rats

Modeling Alzheimer’s disease in transgenic rats

An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

Modulation of inflammation in transgenic models of Alzheimer’s disease

Modulation of inflammation in transgenic models of Alzheimer’s disease

Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice

Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice

Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats

Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease

Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity

Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity

Related objects